Benefits of RT-CGM During Pregnancy

pregnant patient with physician

Pregnant women with diabetes are at higher risk of adverse pregnancy outcomes.¹

Tighter glucose targets are suggested to improve glycemic control, but require a closer glucose monitoring.² New pregnancy indication for Dexcom Continuous Glucose Monitoring (CGM) System can enable more effective diabetes management for pregnant women.

These short educational videos featuring Dr Celeste Durnwald will highlight benefits, clinical advantages, and practical application of CGM use during pregnancy for all people with diabetes (T1, T2, GDM).

In these videos, you will learn about:

CGM standards of care, the importance of tighter targets to reduce complications
How to personalize CGM alerts during pregnancy
Clinical evidence and recommended time-in-range (TIR) during pregnancy
Benefits, customization options, and how patients and families can use Share/Follow feature

Use of Dexcom RT-CGM During Pregnancy - Video 1

Dexcom G7 Alert Customization during Pregnancy - Video 2

Understanding Dexcom G7 Data in Pregnancy - Video 3

Leveraging Remote Monitoring During Pregnancy - Video 4

Dr Celeste Durnwald

Dr Celeste Durnwald, MD is a practicing physician and an Associate Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania.

^{The information you see or hear at this event provides details about medical products which are not available in all countries, may have different indications, and/or have not received approval or market clearance by all governmental regulatory bodies throughout the world. Nothing shown or stated herein should be construed as a solicitation, advertisement, or promotion of any product, or of an indication of any specific use for any product, which is not authorized by the laws and regulations of the country where you reside.}

^{The content may include the presenter’s own experience sharing and data – please do not record or distribute the presentation slides.}

^{1.Negrato CA, Mattar R, Gomes MB. Adverse pregnancy outcomes in women with diabetes. Diabetol Metab Syndr. 2012 Sep 11;4(1):41. doi: 10.1186/1758-5996-4-41. PMID: 22964143; PMCID: PMC3514247.}

^{2.American Diabetes Association Professional Practice Committee; 6. Glycemic Targets:}^{Standards of Medical Care in Diabetes—2022}^.^{Diabetes Care}^{1 January 2022; 45 (Supplement_1): S83–S96.}^{https://doi.org/10.2337/dc22-S006}